CYDY - CytoDyn inks leronlimab distribution deal in India for COVID-19
CytoDyn (CYDY) has executed an exclusive supply and distribution agreement with Macleods Pharmaceuticals in India.This commercial agreement will enable Macleods to sell leronlimab in India following regulatory clearance. “We believe there is an immediate need for leronlimab in our country, to save COVID-19 infected patients who are on ventilators. We need to bring this product to market ASAP for them!”, commented Vijay Agarwal, a Business Development Director at Macleods.Macleods specializes in the development and manufacturing of active pharmaceutical ingredients and finished dosage pharmaceutical formulations.
For further details see:
CytoDyn inks leronlimab distribution deal in India for COVID-19